Dapagliflozin 006 Study Group Long-term Efficacy of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Receiving High Doses of Insulin: A Randomized Trial. This evidence concerns the gene INS and type 2 diabetes mellitus.